Neratinib
CAS NO.: 698387-09-6
MF: C30H29ClN6O3
EINECS NO.: 811-237-1
MF: C30H29ClN6O3
EINECS NO.: 811-237-1
API231
Quantity
![]()

Neratinib is a protein kinase inhibitor used to treat breast cancer that over expresses the HER2 receptor.
![]()
Neratinib is used for use as an extended adjuvant treatment in adult patients with early
stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy
As an irreversible inhibitor, neratinib may circumvent acquired resistance developed against reversible inhibitors, including gefitinib .



